Literature DB >> 10698880

Hypersensitivity reaction to balsalazide.

V Adhiyaman1, A Vaishnavi, S Froese.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698880      PMCID: PMC27304          DOI: 10.1136/bmj.320.7235.613

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Mesalazine induced lupus-like syndrome.

Authors:  M T Pent; S Ganapathy; C D Holdsworth; K C Channer
Journal:  BMJ       Date:  1992-07-18

2.  Pericardial effusion during treatment with 5-aminosalicylic acid in a patient with Crohn's disease.

Authors:  H Jenss; E W Becker; P Weber
Journal:  Am J Gastroenterol       Date:  1990-03       Impact factor: 10.864

3.  Sulphasalazine-induced lupus syndrome in ulcerative colitis.

Authors:  I D Griffiths; S P Kane
Journal:  Br Med J       Date:  1977-11-05

4.  Sulphasalazine-induced lupus-like syndrome with cardiac tamponade in a patient with ulcerative colitis.

Authors:  G Deboever; R Devogelaere; G Holvoet
Journal:  Am J Gastroenterol       Date:  1989-01       Impact factor: 10.864

5.  Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.

Authors:  F M Habal; G R Greenberg
Journal:  Am J Gastroenterol       Date:  1988-01       Impact factor: 10.864

  5 in total
  3 in total

1.  5-ASA induced recurrent myopericarditis and cardiac tamponade in a patient with ulcerative colitis.

Authors:  Irene Sonu; Robert Wong; Michael E Rothenberg
Journal:  Dig Dis Sci       Date:  2013-01-30       Impact factor: 3.199

Review 2.  5-Aminosalicylic Acid-Associated Myocarditis and Pericarditis: A Narrative Review.

Authors:  Glen Brown
Journal:  Can J Hosp Pharm       Date:  2016-12-23

3.  Stress degradation studies and development of stability-indicating TLC-densitometry method for determination of prednisolone acetate and chloramphenicol in their individual and combined pharmaceutical formulations.

Authors:  Syed Ghulam Musharraf; Urooj Fatima; Rahat Sultana
Journal:  Chem Cent J       Date:  2012-01-22       Impact factor: 4.215

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.